1. Home
  2. FATE vs ILLR Comparison

FATE vs ILLR Comparison

Compare FATE & ILLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • ILLR
  • Stock Information
  • Founded
  • FATE 2007
  • ILLR 2015
  • Country
  • FATE United States
  • ILLR United States
  • Employees
  • FATE N/A
  • ILLR N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • ILLR Investment Managers
  • Sector
  • FATE Health Care
  • ILLR Finance
  • Exchange
  • FATE Nasdaq
  • ILLR Nasdaq
  • Market Cap
  • FATE 142.4M
  • ILLR 304.1M
  • IPO Year
  • FATE 2013
  • ILLR N/A
  • Fundamental
  • Price
  • FATE $1.20
  • ILLR $1.81
  • Analyst Decision
  • FATE Hold
  • ILLR
  • Analyst Count
  • FATE 10
  • ILLR 0
  • Target Price
  • FATE $6.75
  • ILLR N/A
  • AVG Volume (30 Days)
  • FATE 1.7M
  • ILLR 1.0M
  • Earning Date
  • FATE 02-24-2025
  • ILLR 02-19-2025
  • Dividend Yield
  • FATE N/A
  • ILLR N/A
  • EPS Growth
  • FATE N/A
  • ILLR N/A
  • EPS
  • FATE N/A
  • ILLR N/A
  • Revenue
  • FATE $13,447,000.00
  • ILLR $45,244,000.00
  • Revenue This Year
  • FATE N/A
  • ILLR N/A
  • Revenue Next Year
  • FATE N/A
  • ILLR N/A
  • P/E Ratio
  • FATE N/A
  • ILLR N/A
  • Revenue Growth
  • FATE N/A
  • ILLR N/A
  • 52 Week Low
  • FATE $1.04
  • ILLR $0.66
  • 52 Week High
  • FATE $8.83
  • ILLR $8.86
  • Technical
  • Relative Strength Index (RSI)
  • FATE 37.03
  • ILLR N/A
  • Support Level
  • FATE $1.21
  • ILLR N/A
  • Resistance Level
  • FATE $1.49
  • ILLR N/A
  • Average True Range (ATR)
  • FATE 0.09
  • ILLR 0.00
  • MACD
  • FATE 0.02
  • ILLR 0.00
  • Stochastic Oscillator
  • FATE 10.34
  • ILLR 0.00

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About ILLR Triller Group Inc. Common Stock

Triller Group Inc is a us-based company that operates its businesses through Triller Corp which operates as a technology platform and AGBA Group Holding Limited operates as an insurance and wealth distribution platform.

Share on Social Networks: